HataKMiuraM.Evaluation of an immunoassay method for the determination of urinary collagen crosslink excretion. Ann Clin Biochem1994; 31: 374–5.
2.
SeyedinSMKungVTDaniloffYNHesleyRPGomezBNielsenLAImmunoassay for urinary pyridinoline; the new marker for bone resorption. J Bone Miner Res1993; 8: 635–41.
3.
DelmasPGineytsEBertholinAGarneroPMarchandF.Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget's disease. J Bone Miner Res1993; 8: 643–9.
4.
SeibelMWoitgeHScheidt-NaveCZipfADuncanANicolPPopulation screening for bone resorption using pyridinium crosslinks of collagen: Comparison of direct ELISA with HPLC assays. Calcif Tiss Int1993; 52: S6.
5.
BlandJMAltmanDG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet1986; i: 307–10.
6.
EyreDRKoobTJVan NessKP. Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal Biochem1984; 137: 380–8.
7.
RobinsSWoitgeHHesleyRJuJSeyedinSSeibelM.Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker of bone resorption. J Bone Miner Res1994; 9: 1643–9.
8.
SeibelMJDuncanARobinsSP. Urinary hydroxypyridinium crosslinks provide indices of cartilage and bone involvement in arthritic disease. J Rheumatol1989; 16: 964–70.
9.
AstburyCBirdHAMcLarenAMRobinsSP. Urinary excretion of pyridinium crosslinks of collagen correlated with joint damage in arthritis. Br J Rheumatol1994; 33: 11–15.